Statistics for ABIONYX Pharma SA (id:10940 ABNX)

Valuation metrics

Market cap

43.87M

Enterprise value

38.96M

Trailing P/E (ttm)

-10.38

Forward P/E

-6.03

PEG ratio

-6.03

Price/Sales (ttm)

9.03

Price/Book (mrq)

4.35

Enterprise Value/Revenue

8.02

Enterprise Value/EBITDA

-12.22

Overview

Shares outstanding

34.66M

Float

19.72M

Shares short

% Held by insiders

0.32%

% Held by institutions

0.05%

Average volume (10 days)

36.37K

Average volume (90 days)

Price summary

52-Week low

0.91

52-Week high

1.50

52-Week change

1.12%

Beta

0.05

50-Day moving average

1.27

200-Day moving average

1.19

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

December 31th, 2023

Profitability

Profit margin

-69.15%

Operating margin

-90.61%

Operational effectiveness

Return on assets

-14.12%

Return on equity

-47.16%

Income statement

Revenue (ttm)

0.16

Revenue per share (ttm)

0.16

Quarterly revenue growth (yoy)

Gross profit (ttm)

618.00K

EBITDA

-3,188,000.00

Net income to common (ttm)

-3,358,000.00

Diluted EPS (ttm)

-0.10

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

5.30M

Total cash per share (mrq)

0.16

Total debt (mrq)

3.17M

Total Debt/Equity (mrq)

33.56

Current ratio (mrq)

228.30%

Book value per share (mrq)

0.29

Cash flow

Cash flow statement

-3,033,000.00

Levered free cash flow (LFCF)

-1,954,375.00